Tudor-eliade E. Ciuleanu
Institutul Oncologic Prof. Dr. Ion Chiricuta
Cluj-napoca, CJ, Romania
Cluj-napoca, CJ, Romania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Patient-reported outcomes with tarlatamab in extensive-stage small cell lung cancer after platinum-based chemotherapy: results from the phase 3 DeLLphi-304 trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 08, 2026
Chemo-Radio-Immunotherapy Strategies to Prevent Immune Resistance in Non-Small Cell Lung Cancer.
Journal: Cancers
Published: December 07, 2025
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer.
Journal: Nature
Published: November 04, 2025
Real-world benchmarks for metastatic urothelial carcinoma: a single-center analysis of two standard immunotherapy pathways in Romania.
Journal: Medicine and pharmacy reports
Published: August 18, 2025
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial.
Journal: Nature cancer
Published: August 13, 2025
Risk Stratification Using a Perioperative Nomogram for Predicting the Mortality of Bladder Cancer Patients Undergoing Radical Cystectomy.
Journal: Journal of clinical medicine
Published: June 16, 2025
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.
Journal: The New England journal of medicine
Published: June 02, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.
Journal: The New England journal of medicine
Published: June 02, 2025
The miRNA-immune axis in bladder cancer: systematic evidence for a new era of immunotherapy precision.
Journal: Frontiers in immunology
Published: June 01, 2025
Lymphovascular Invasion Is a Predictor of Clinical Outcomes in Bladder Cancer Patients Treated with Radical Cystectomy.
Journal: Journal of clinical medicine
Published: May 28, 2025
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 17, 2025
Impact of patient and tumor characteristics on various aspects of the non-small cell lung cancer patient journey in Romania, Bulgaria, Serbia: A multicenter, non-interventional, retrospective cohort study.
Journal: Cancer treatment and research communications
Published: January 22, 2025
Last Updated: 09/26/2026